Intranasal delivery of thin-film freeze-dried monoclonal antibodies using a powder nasal spray system
Description
Monoclonal antibodies (mAbs) administered intranasally as dry powders can be potentially applied for the treatment or pre-exposure prevention of viral infections in the upper respiratory tract. However, a method to transform the mAbs from liquid to